Cargando…

Efficacy and tolerability of brivaracetam monotherapy in childhood and juvenile absence epilepsy: An innovative adaptive trial design

OBJECTIVE: Despite introduction of several antiseizure medications over the past two decades, treatment options for childhood absence epilepsy (CAE) and juvenile absence epilepsy (JAE) remain limited. We report the innovative adaptive design of an ongoing phase 2/3 trial to evaluate efficacy, safety...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bast, Thomas, Schulz, Anne‐Liv, Floricel, Florin, Morita, Diego, Cleveland, Jody M., Elshoff, Jan‐Peer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712476/ https://www.ncbi.nlm.nih.gov/pubmed/35844134 http://dx.doi.org/10.1002/epi4.12628

Ejemplares similares

Pharmacokinetics, safety, and tolerability of intravenous brivaracetam in pediatric patients with epilepsy: An open‐label trial
por: Farkas, Mark Kristof, et al.
Publicado: (2022)

Tolerability and efficacy of adjunctive brivaracetam in adults with focal seizures by concomitant antiseizure medication use: Pooled results from three phase 3 trials
por: Ryvlin, Philippe, et al.
Publicado: (2022)

Brivaracetam substituting other antiepileptic treatments: Results of a retrospective study in German epilepsy centers
por: Lerche, Holger, et al.
Publicado: (2020)

Profile of brivaracetam and its potential in the treatment of epilepsy
por: Ferlazzo, Edoardo, et al.
Publicado: (2015)

Brivaracetam in the Treatment of Patients with Epilepsy—First Clinical Experiences
por: Zahnert, Felix, et al.
Publicado: (2018)

Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records
por: Villanueva, Vicente, et al.
Publicado: (2023)

Emerging drugs for partial-onset epilepsy: a review of brivaracetam
por: Gao, Lan, et al.
Publicado: (2016)

New developments in the management of partial-onset epilepsy: role of brivaracetam
por: Coppola, Giangennaro, et al.
Publicado: (2017)

Brivaracetam in the treatment of epilepsy: a review of clinical trial data
por: Feyissa, Anteneh M
Publicado: (2019)

Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST)
por: Lattanzi, Simona, et al.
Publicado: (2021)

First clinical postmarketing experiences in the treatment of epilepsies with brivaracetam: a retrospective observational multicentre study
por: Menzler, Katja, et al.
Publicado: (2019)

Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)
por: Lattanzi, Simona, et al.
Publicado: (2021)

Safety and Tolerability of Adjunctive Brivaracetam in Pediatric Patients < 16 Years with Epilepsy: An Open-Label Trial
por: Liu, Edwin, et al.
Publicado: (2019)

Effect of Brivaracetam on Efficacy and Tolerability in Patients With Brain Tumor-Related Epilepsy: A Retrospective Multicenter Study
por: Maschio, Marta, et al.
Publicado: (2020)

Brivaracetam population pharmacokinetics in children with epilepsy aged 1 month to 16 years
por: Schoemaker, Rik, et al.
Publicado: (2017)

Α Multicenter Retrospective Study Evaluating Brivaracetam in the Treatment of Epilepsies in Clinical Practice
por: Stefanatou, Maria, et al.
Publicado: (2021)

Clinical and Electroencephalography Assessment of the Effects of Brivaracetam in the Treatment of Drug-Resistant Focal Epilepsy
por: Savastano, Ersilia, et al.
Publicado: (2021)

Safety and efficacy of brivaracetam in children epilepsy: a systematic review and meta-analysis
por: Song, Ting, et al.
Publicado: (2023)

Overnight switch from levetiracetam to brivaracetam. Safety and tolerability
por: Abraira, L., et al.
Publicado: (2021)

Acute and long‐term effects of brivaracetam and brivaracetam–diazepam combinations in an experimental model of status epilepticus
por: Niquet, Jerome, et al.
Publicado: (2017)

Long‐term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11‐year, open‐label, follow‐up trial
por: O’Brien, Terence J., et al.
Publicado: (2020)

Cortical and subcortical brain alterations in Juvenile Absence Epilepsy
por: Tondelli, Manuela, et al.
Publicado: (2016)

Brivaracetam in treating epileptic encephalopathy and refractory focal epilepsies in patients under 14 years of age
por: RUSSO, Angelo, et al.
Publicado: (2021)

Therapeutic Options for Childhood Absence Epilepsy
por: Rinaldi, Victoria Elisa, et al.
Publicado: (2021)

Efficacy, Retention, and Tolerability of Brivaracetam in Patients With Epileptic Encephalopathies: A Multicenter Cohort Study From Germany
por: Willems, Laurent M., et al.
Publicado: (2018)

Facial Emotion Recognition in Patients with Juvenile Myoclonic Epilepsy
por: Dunkel, Hannah, et al.
Publicado: (2023)

A review of the pharmacology and clinical efficacy of brivaracetam
por: Klein, Pavel, et al.
Publicado: (2018)

Adjunctive Brivaracetam in Older Patients with Focal Seizures: Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)
por: Lattanzi, Simona, et al.
Publicado: (2022)

Juvenile absence epilepsy: integrating photosensitivity and autonomic focal epileptic symptoms
por: León-Ruiz, Moisés, et al.
Publicado: (2022)

Therapeutic Outcomes and Prognostic Factors in Childhood Absence Epilepsy
por: Kim, Hye Ryun, et al.
Publicado: (2016)

A Practical Guide to Treatment of Childhood Absence Epilepsy
por: Kessler, Sudha Kilaru, et al.
Publicado: (2019)

Childhood Absence Epilepsy Associated With Concomitant Centrotemporal Spikes
por: Jocic-Jakubi, Bosanka, et al.
Publicado: (2022)

Impaired rich-club connectivity in childhood absence epilepsy
por: Yu, Yadong, et al.
Publicado: (2023)

Functional brain network characteristics are associated with epilepsy severity in childhood absence epilepsy
por: Drenthen, Gerhard S., et al.
Publicado: (2020)

Synthetic Approaches toward the Synthesis of Brivaracetam: An Antiepileptic Drug
por: Gayke, Manoj, et al.
Publicado: (2022)

Memory Functioning in Children with Epilepsy: Frontal Lobe Epilepsy, Childhood Absence Epilepsy, and Benign Epilepsy with Centrotemporal Spikes
por: Lopes, Ana Filipa, et al.
Publicado: (2014)

Absence Seizures as a Feature of Juvenile Myoclonic Epilepsy in Rhodesian Ridgeback Dogs
por: Wielaender, F., et al.
Publicado: (2017)

Childhood Absence Epilepsy Successfully Treated with the Paleolithic Ketogenic Diet
por: Clemens, Zsófia, et al.
Publicado: (2013)

Abnormal cortical thickness connectivity persists in childhood absence epilepsy
por: Curwood, Evan K, et al.
Publicado: (2015)

Feasibility of a Mobile Cognitive Intervention in Childhood Absence Epilepsy
por: Glynn, Peter, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7hgenil93d2k9bdmc417fi7953